US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

iRadimed Corporation - Common Stock (NQ:IRMD)

76.68 -9.06 (-10.57%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRadimed Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
From iRadimed Corporation
Via GlobeNewswire
News headline image
Exploring NASDAQ:IRMD's quality characteristics. ↗
Reasonable growth and debt and a high ROIC for IRADIMED CORP (NASDAQ:IRMD). 
Via Chartmill
News headline image
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For February 8, 2024 ↗
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
News headline image
iRadimed's Earnings Outlook ↗
 
Via Benzinga
News headline image
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout ↗
 
Via Benzinga
News headline image
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
Masimo Stock Gets Relative Strength Rating Upgrade ↗
The Relative Strength Rating for Masimo stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 78. 
Via Investor's Business Daily
News headline image
Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2024 Investor Conference
Phoenix, Arizona and New York, New York--(Newsfile Corp. - September 30, 2024) - Lytham... 
Via Newsfile
News headline image
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Trading to commence effective on the market open June 14, 2024 
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024 ↗
IRMD stock results show that iRadimed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
From iRadimed Corporation
Via GlobeNewswire
News headline image
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade ↗
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For November 3, 2023 ↗
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >